Z79.89 — Other long term (current) drug therapy
Z79.89 is a non-billable header ICD-10-CM code for other long term (current) drug therapy. It cannot be billed on its own: choose one of the more specific child codes below.
Other codes that can never be billed with Z79.89
These codes carry an Excludes1 note pointing at Z79.89. The conflict binds both ways, but ICD-10-CM only writes it down on one side — so you would not find this by reading Z79.89 alone.
- Z79.81Long term (current) use of agents affecting estrogen receptors and estrogen levels
Risk adjustment
Z79.89 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Code history
Z79.89 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.
Code to one of these instead Z79.89
3 child codes. Green means billable.
Related codes at this level
Codes that share Z79.8. If Z79.89 is not quite right, the correct code is usually one of these.
- Z79.81Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.82Long term (current) use of aspirin
- Z79.83Long term (current) use of bisphosphonates
- Z79.84Long term (current) use of oral hypoglycemic drugs
- Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
Questions about Z79.89
- Is Z79.89 a billable ICD-10-CM code?
- No. Z79.89 is a non-billable header code. Code to a higher level of specificity using one of its child codes.
- Where does Z79.89 sit in the tabular list?
- Factors influencing health status and contact with health services (Z00-Z99), in the block Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99).